Mylan to acquire thrombosis business in Europe from Aspen Pharmacare for EUR 641.9 mn
Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.